Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus Infection

QR Code

Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus Infection

ABSTRACT HBsAg and HBeAg have gained traction as biomarkers of control and clearance during chronic hepatitis B virus infection (CHB). Improved understanding of the clearance correlates of these proteins could help inform improvements in patient-stratified care and advance insights into the underlyi...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Louise O. Downs, David A. Smith, Sheila F. Lumley, Meha Patel, Anna L. McNaughton, Jolynne Mokaya, M. Azim Ansari, Hizni Salih, Kinga A. Várnai, Oliver Freeman, Sarah Cripps, Jane Phillips, Jane Collier, Kerrie Woods, Keith Channon, Jim Davies, Eleanor Barnes, Katie Jeffery, Philippa C. Matthews
Format:	article
Langue:	EN
Publié:	American Society for Microbiology 2019
Sujets:	biomarker health informatics hepatitis B virus surface antigen viral clearance Microbiology QR1-502
Accès en ligne:	https://doaj.org/article/4a37f4cf6e4142c29019029dd957b26a
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated Area
par: Chen-Hsuan Wu, et autres
Publié: (2017)

Alteration of the Immune Microenvironment in HBsAg and HBeAg Dual-Positive Pregnant Women Presenting a High HBV Viral Load
par: Gao F, et autres
Publié: (2021)

Prediction for HBsAg seroconversion in children with chronic hepatitis B
par: Yan-Wei Zhong, et autres
Publié: (2021)

Understanding the antiviral effects of RNAi-based therapy in HBeAg-positive chronic hepatitis B infection
par: Sarah Kadelka, et autres
Publié: (2021)

Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL
par: Chih-Chien Yao, et autres
Publié: (2017)

Pegylated Interferon Treatment for the Effective Clearance of Hepatitis B Surface Antigen in Inactive HBsAg Carriers: A Meta-Analysis
par: Aixin Song, et autres
Publié: (2021)

Removal of Hepatitis B virus surface HBsAg and core HBcAg antigens using microbial fuel cells producing electricity from human urine
par: Grzegorz Pasternak, et autres
Publié: (2019)

Sequence variations of full-length hepatitis B virus genomes in Chinese patients with HBsAg-negative hepatitis B infection.
par: Fung-Yu Huang, et autres
Publié: (2014)

Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines
par: Nao Nishida, et autres
Publié: (2021)

RESULTS OF GENOTYPING HEPATITIS VIRUS B IN HBsAg-NEGATIVE BLOOD DONORS IN ASTANA, KAZAKHSTAN
par: Yu. V. Ostankova, et autres
Publié: (2018)

Amino acid residues at core protein dimer-dimer interface modulate multiple steps of hepatitis B virus replication and HBeAg biogenesis.
par: Hui Liu, et autres
Publié: (2021)

Sophisticated viral quasispecies with a genotype-related pattern of mutations in the hepatitis B X gene of HBeAg-ve chronically infected patients
par: Maria Francesca Cortese, et autres
Publié: (2021)

A Missense Variant in Granulysin is Associated with the Efficacy of Pegylated-Interferon-Alpha Therapy in Chinese Patients with HBeAg-Positive Chronic Hepatitis B
par: Li J, et autres
Publié: (2021)

Amino acid residues at core protein dimer-dimer interface modulate multiple steps of hepatitis B virus replication and HBeAg biogenesis
par: Hui Liu, et autres
Publié: (2021)

In vitro expression of precore proteins of hepatitis B virus subgenotype A1 is affected by HBcAg, and can affect HBsAg secretion
par: Aurélie Deroubaix, et autres
Publié: (2021)

Bayesian analysis of cytokines and chemokine identifies immune pathways of HBsAg loss during chronic hepatitis B treatment
par: Sriram Narayanan, et autres
Publié: (2021)

Analysis of the Physicochemical Properties, Replication and Pathophysiology of a Massively Glycosylated Hepatitis B Virus HBsAg Escape Mutant
par: Md. Golzar Hossain, et autres
Publié: (2021)

Meta-omics characteristics of intestinal microbiota associated to HBeAg seroconversion induced by oral antiviral therapy
par: Yu-Li Zeng, et autres
Publié: (2021)

Estimating age-related incidence of HBsAg seroclearance in chronic hepatitis B virus infections of China by using a dynamic compartmental model
par: Jian Zu, et autres
Publié: (2017)

High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B.
par: Wai-Kay Seto, et autres
Publié: (2012)

Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase III Clinical Trial
par: Sheikh Mohammad Fazle Akbar, et autres
Publié: (2021)

Tratamiento de infección por virus de hepatitis B con entecavir A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. Chang T, Gish R G, de Man R, Gadano A. N Engl J Med 2006; Vol 354: 1001-10
par: Calvo A,Mario
Publié: (2006)

Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice
par: Lu Zong, et autres
Publié: (2019)

Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients with High Serum Fucosyl-Agalactosyl IgG
par: Cheng-Hsun Ho, et autres
Publié: (2017)

Frequency of hepatitis B virus-DNA among hepatitis B surface-Ag negative, anti-hepatitis B core antibody-positive blood donors in Yazd, Iran
par: Mahtab Vaziri, et autres
Publié: (2021)

Evolution of full-length genomes of HBV quasispecies in sera of patients with a coexistence of HBsAg and anti-HBs antibodies
par: Tai-Cheng Zhou, et autres
Publié: (2017)

Prevalence of HBsAg among reproductive age couples in Chongqing: A population-based, cross-sectional study.
par: Qing Chen, et autres
Publié: (2021)

Prevalence of HBsAg among reproductive age couples in Chongqing: A population-based, cross-sectional study
par: Qing Chen, et autres
Publié: (2021)

Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)
par: Anna L. McNaughton, et autres
Publié: (2019)

A novel piperazine derivative that targets hepatitis B surface antigen effectively inhibits tenofovir resistant hepatitis B virus
par: S. Kiruthika, et autres
Publié: (2021)

E2 Site Mutations in S Protein Strongly Affect Hepatitis B Surface Antigen Detection in the Occult Hepatitis B Virus
par: Hao Wang, et autres
Publié: (2021)

Outcome after kidney transplantation in hepatitis B surface antigen-positive patients
par: Hyejin Mo, et autres
Publié: (2021)

Circulating hepatitis B surface antigen particles carry hepatocellular microRNAs.
par: Luisa Novellino, et autres
Publié: (2012)

Artificial neural network accurately predicts hepatitis B surface antigen seroclearance.
par: Ming-Hua Zheng, et autres
Publié: (2014)

The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing
par: Ying Wang, et autres
Publié: (2021)

Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B
par: En-Qiang Chen, et autres
Publié: (2017)

THE DYNAMICS OF TITERS CHANGES OF SPECIFIC IMMUNOGLOBULINS TO HBsAg IN SERUM AND YOLK OF QUAIL EGGS IN CASE OF USING OF DIFFERENT PREPARATION FOR IMMUNIZATION
par: V. B. Sboychakov, et autres
Publié: (2014)

DNA removal from a purification process of recombinant hepatitis B surface antigen
par: Beldarraín Iznaga,Alejandro, et autres
Publié: (2007)

Biological Characterization of Hepatitis B virus Genotypes: Their Role in Viral Replication and Antigen Expression
par: María Mercedes Elizalde, et autres
Publié: (2021)

Hepatitis B virus middle surface antigen loss promotes clinical variant persistence in mouse models
par: Junyu Lin, et autres
Publié: (2021)